APA

Allard S. D., De Keersmaecker B., de Goede A. L., Verschuren E. J., Koetsveld J., Reedijk M. L., Wylock C., De Bel A. V., Vandeloo J., Pistoor F., Heirman C., Beyer W. E. P., Eilers P. H. C., Corthals J., Padmos I., Thielemans K., Osterhaus A. D. M. E., Lacor P., van der Ende M. E., Aerts J. L., van Baalen C. A. & Gruters R. A. (20120412). A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption. : Clinical immunology (Orlando, Fla.).

Chicago

Allard Sabine D, De Keersmaecker Brenda, de Goede Anna L, Verschuren Esther J, Koetsveld Jeanette, Reedijk Mariska L, Wylock Carolien, De Bel Annelies V, Vandeloo Judith, Pistoor Frank, Heirman Carlo, Beyer Walter E P, Eilers Paul H C, Corthals Jurgen, Padmos Iman, Thielemans Kris, Osterhaus Albert D M E, Lacor Patrick, van der Ende Marchina E, Aerts Joeri L, van Baalen Carel A and Gruters Rob A. 20120412. A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption. : Clinical immunology (Orlando, Fla.).

Harvard

Allard S. D., De Keersmaecker B., de Goede A. L., Verschuren E. J., Koetsveld J., Reedijk M. L., Wylock C., De Bel A. V., Vandeloo J., Pistoor F., Heirman C., Beyer W. E. P., Eilers P. H. C., Corthals J., Padmos I., Thielemans K., Osterhaus A. D. M. E., Lacor P., van der Ende M. E., Aerts J. L., van Baalen C. A. and Gruters R. A. (20120412). A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption. : Clinical immunology (Orlando, Fla.).

MLA

Allard Sabine D, De Keersmaecker Brenda, de Goede Anna L, Verschuren Esther J, Koetsveld Jeanette, Reedijk Mariska L, Wylock Carolien, De Bel Annelies V, Vandeloo Judith, Pistoor Frank, Heirman Carlo, Beyer Walter E P, Eilers Paul H C, Corthals Jurgen, Padmos Iman, Thielemans Kris, Osterhaus Albert D M E, Lacor Patrick, van der Ende Marchina E, Aerts Joeri L, van Baalen Carel A and Gruters Rob A. A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption. : Clinical immunology (Orlando, Fla.). 20120412.